Task: Answer the multiple choice question.
Question: Which compound exhibits a -17.955% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. Cl.c1ccc(CSc2nnc([C@@H]3CCCN3)o2)cc1
b. CCOC(=O)N1CCC(N2CCN(Cc3ccc(F)c(F)c3)C(CCO)C2)CC1
c. O=C(NC1CCSc2ccccc21)c1cc(S(=O)(=O)N2CCOCC2)ccc1Cl
Answer: c. O=C(NC1CCSc2ccccc21)c1cc(S(=O)(=O)N2CCOCC2)ccc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(NC1CCSc2ccccc21)c1cc(S(=O)(=O)N2CCOCC2)ccc1Cl
O=C(NC1CCSc2ccccc21)c1cc(S(=O)(=O)N2CCOCC2)ccc1Cl
2-chloro-N-(3,4-dihydro-2H-thiochromen-4-yl)-5-morpholin-4-ylsulfonylbenzamide